This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...
Montreal Gazette on MSNOpinion
The Right Chemistry: Ripples of discovery created a new wave of weight-loss medications
When it comes to pharmacology, the big story these days is the development of the “glucagon-like peptide-1 (GLP-1) mimics,” ...
In 2025, the FDA approved 73 first-time generic drugs. Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...
Novo Nordisk AS was sued in federal court Friday with allegations that it monopolized the blockbuster weight loss medication Victoza through an illegal deal with a competitor to delay the generic, ...
News-Medical.Net on MSN
GLP-1 weight-loss drugs show early promise for treating addiction
By Tarun Sai Lomte From laboratory models to small human trials, a new review explores whether popular metabolic drugs could help curb alcohol, nicotine, and drug use, while underscoring how much ...
After GLP-1 injections end, weight often returns. Eggs may naturally boost satiety, protect muscle, and restore key nutrients ...
Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a ...
The Independent on MSN
This is what happens to your body when you come off weight-loss jabs
The truth about what happens to your body when you come off weight-loss jabs - Many returned to their original weight within ...
Meals may be shared, but so is scrutiny. With GLP-1s on the table, thinness remains the prized serving in many homes ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...
Everyday Health on MSN
Here are the best telehealth companies for Ozempic and GLP-1 therapy in 2026
Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable places to get a prescription online.
Irish Examiner on MSN
Hungry for change: How will 2026 reshape the way we treat obesity?
From the King Kong of weight-loss jabs to the Godzilla of the category, the GLP-1 industry is undergoing big changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results